Figure 4From: Retrospective analysis of the frequency of centrofacial telangiectasia in systemic sclerosis patients treated with bosentan or ilomedinClinical appearance centrofacial telangiectasia (TAE) in patients treated with iloprost or bosentan after ten months. (a) Close-up and (b) diascopy of the cheek of a 57-year-old man treated with bosentan; (c) close-up of the cheek of 54-year-old woman treated with iloprost.Back to article page